[singaporean1964]

Supreme Court: Pfizer, Moderna May Own Your Genes Once You’re Injected With Their Lab-Created mRNA, DNA[/on 09/03/2021 by EraOfLight — Leave a reply[/size][/color]
This article is prefaced with a shout-out to the good Dr. Carrie Madej (maa-DAY).
She is one of thousands of doctors and scientists worldwide suddenly labeled “conspiracy theorists” and “disinformation” by mainstream and social media. Dr. Madej tells peer-reviewed truth about COVID-19 and experimental shots. She is still on Twitter and Facebook for now. Dr. Madej is also featured in a viral video warning people about experiment mRNA and viral vector shots.
She said in a recent interview with The New American:

[i][b]“The Supreme Court ruled that if there is anything synthetic, not from nature, inside of our genome, then whoever owns the patent on those synthetic parts now owns part or all of you as a human. That means Bill and Melinda Gates, The Department of Defense, [and others] can literally own a human being. If this synthetic code is taken up into your genome, by law, you could be owned overnight.”[/b][/i]

Dr. Madej told The COVID Blog via email that she learned about gene patenting from Dr. Craig Venter. He spoke about it during a world symposium presentation. All legitimate doctors and scientists welcome fact-checking and peer-review. Turns out Dr. Madej is onto something, and further affirms every reason not to volunteer for these experimental injections.
[size=11]Man-made bacteria and genetically-modified mice are patentable
The case of [i]Diamond v. Chakrabarty[/i], 447 U.S. 303 (1980) is the first time the U.S. Supreme Court heard a patent case involving naturally-occurring processes and/or organisms. Dr. Ananda Mohan Chakrabarty invented a species of oil-eating bacteria while working at General Electric in 1971. His invention streamlined the process of cleaning up oil spills.
He filed a first-of-its-kind patent for the new genetically-modified bacteria species. The United Kingdom had already granted the patent. But the U.S. Patent and Trademark Office denied the patent because it determined the invention was a living organism. The U.S. Court of Customs and Patent Appeals (now the United States Court of Appeals for the Federal Circuit) reversed the decision. It ruled that just because micro-organisms are alive doesn’t mean they cannot be patented.
The U.S. Supreme Court, in a 5-4 decision, affirmed. It ruled, in part:[/size]

Living, man-made micro-organism is patentable subject matter as a “manufacture” or “composition of matter” within the meaning of the Patent Act of 1952. The fact that the organism sought to be patented is alive is no bar to patentability.

The case paved the way for biotechnology companies and universities. The OncoMouse, patented by Harvard in 1988, was the first mammal ever patented. Harvard scientists genetically-modified mice to be predisposed to cancer (thus the “onco” prefix) so other scientists could study the disease.[